CAS RN: 1369761-01-2

Cerdulatinib HCl salt

Product Availability

Choose a grade to view its available package options.

12 package records11 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250510 100mg Out of stock Inquiry
Batchno.20250312 10mg In stock Inquiry
Batchno.20250120 50mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250618 1ml In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260105 100mg In stock Shanghai Inquiry
Batchno.20251128 10mg In stock Shanghai, Wuhan Inquiry
Batchno.20260118 1g In stock Shanghai Inquiry
Batchno.20250509 1mg In stock Shanghai, Wuhan Inquiry
Batchno.20250801 250mg In stock Shanghai Inquiry
Batchno.20250121 25mg In stock Shanghai, Wuhan Inquiry
Batchno.20251007 50mg In stock Shanghai, Wuhan Inquiry
Batchno.20260606 5mg In stock Shanghai, Wuhan Inquiry
  • Product code: starshine_CAS1369761-01-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1369761-01-2 / 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide;hydrochloride

Standard CAS: 1369761-01-2 Multi CAS: No

Basic Information

CAS
1369761-01-2
Multi CAS
No
Molecular Formula
C20H28ClN7O3S
Molecular Weight
482.000000
Exact Mass
481.166287
SMILES
CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N.Cl
InChI
InChI=1S/C20H27N7O3S.ClH/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14;/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25);1H
InChIKey
IYULGYKOHUAYCG-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
32
Aromatic heavy atom count
12
Fraction Csp3
0.45
Rotatable bonds
8
H-bond acceptors
8
H-bond donors
3
Molar refractivity
127.41
TPSA
133.55

LogP / Solubility

WLOGP
1.79
MLOGP
1.61
XLogP3
1.79
Consensus LogP
1.73
Log S (ESOL)
-3.7
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.8
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.24
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.39

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
No
Muegge
Yes
Bioavailability score
0.55
PAINS alerts
1
Leadlikeness
No
Synthetic Accessibility
3

Get In Touch

Contact Us